Testosterone Treatment Linked to Reduced Inhaled Steroid Use
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
New research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
A collaboration between Jiva.ai and Aevice Health has developed a predictive model that identifies potential asthma exacerbations up to 72 hours in advance.
Research using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.
Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.